Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
OrthoSpineNews
MAY 13, 2025
The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.
Let's personalize your content